Stemline Therapeutics Inc (NASDAQ:STML)

16.58
Delayed Data
As of Apr 24
 -0.42 / -2.47%
Today’s Change
10.50
Today|||52-Week Range
18.94
-2.81%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Stemline Therapeutics Inc have a median target of 44.00, with a high estimate of 55.00 and a low estimate of 30.00. The median estimate represents a +165.38% increase from the last price of 16.58.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Stemline Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.46
Sales
$70.2K
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.84%
 
 
 
 
 
 
Growthannually 14.80%
 
 
 
 
 

Sales

Growthquarterly -42.19%
 
 
 
 
 
 
Growthannually -31.90%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account